These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12604714)

  • 1. Pharmacodynamics of selective androgen receptor modulators.
    Yin D; Gao W; Kearbey JD; Xu H; Chung K; He Y; Marhefka CA; Veverka KA; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1334-40. PubMed ID: 12604714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective androgen receptor modulator for hormonal male contraception.
    Chen J; Hwang DJ; Bohl CE; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2005 Feb; 312(2):546-53. PubMed ID: 15347734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.
    Jones A; Hwang DJ; Duke CB; He Y; Siddam A; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2010 Aug; 334(2):439-48. PubMed ID: 20444881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
    Aikawa K; Miyawaki T; Hitaka T; Imai YN; Hara T; Miyazaki J; Yamaoka M; Kusaka M; Kanzaki N; Tasaka A; Shiraishi M; Yamamoto S
    Bioorg Med Chem; 2015 May; 23(10):2568-78. PubMed ID: 25862209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia.
    Nejishima H; Yamamoto N; Suzuki M; Furuya K; Nagata N; Yamada S
    Prostate; 2012 Oct; 72(14):1580-7. PubMed ID: 22430536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator.
    Piu F; Gardell LR; Son T; Schlienger N; Lund BW; Schiffer HH; Vanover KE; Davis RE; Olsson R; Bradley SR
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):129-37. PubMed ID: 18164613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators.
    Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM
    J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a 5-day Hershberger assay using young mature male rats: methyltestosterone and p,p'-DDE, but not fenitrothion, exhibited androgenic or antiandrogenic activity in vivo.
    Sunami O; Kunimatsu T; Yamada T; Yabushita S; Sukata T; Miyata K; Kamita Y; Okuno Y; Seki T; Nakatsuka I; Matsuo M
    J Toxicol Sci; 2000 Dec; 25(5):403-15. PubMed ID: 11201171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.
    Gao W; Reiser PJ; Coss CC; Phelps MA; Kearbey JD; Miller DD; Dalton JT
    Endocrinology; 2005 Nov; 146(11):4887-97. PubMed ID: 16099859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators.
    Kim J; Wu D; Hwang DJ; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2005 Oct; 315(1):230-9. PubMed ID: 15987833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
    Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
    J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
    Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
    Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.
    Chen J; Hwang DJ; Chung K; Bohl CE; Fisher SJ; Miller DD; Dalton JT
    Endocrinology; 2005 Dec; 146(12):5444-54. PubMed ID: 16166218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
    Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
    J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.
    Marhefka CA; Gao W; Chung K; Kim J; He Y; Yin D; Bohl C; Dalton JT; Miller DD
    J Med Chem; 2004 Feb; 47(4):993-8. PubMed ID: 14761201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.
    Ostrowski J; Kuhns JE; Lupisella JA; Manfredi MC; Beehler BC; Krystek SR; Bi Y; Sun C; Seethala R; Golla R; Sleph PG; Fura A; An Y; Kish KF; Sack JS; Mookhtiar KA; Grover GJ; Hamann LG
    Endocrinology; 2007 Jan; 148(1):4-12. PubMed ID: 17008401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f.
    Morimoto M; Amano Y; Oka M; Harada A; Fujita H; Hikichi Y; Tozawa R; Yamaoka M; Hara T
    PLoS One; 2017; 12(12):e0189480. PubMed ID: 29216311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review.
    Machek SB; Cardaci TD; Wilburn DT; Willoughby DS
    Steroids; 2020 Dec; 164():108753. PubMed ID: 33148520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor.
    Yin D; Xu H; He Y; Kirkovsky LI; Miller DD; Dalton JT
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1323-33. PubMed ID: 12604713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.